| Dr Keyur Parikh, PHARMD | |
|
6775 Quail Hill Pkwy, Irvine, CA 92603-4233 | |
| (949) 823-8915 | |
| Not Available |
| Full Name | Dr Keyur Parikh |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 6775 Quail Hill Pkwy, Irvine, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497341143 | NPI | - | NPPES |
| 53666 | Other | CA | CA BOARD OF PHARMACY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 53666 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Keyur Parikh, PHARMD 6775 Quail Hill Pkwy, Irvine, CA 92603-4233 Ph: (949) 823-8915 | Dr Keyur Parikh, PHARMD 6775 Quail Hill Pkwy, Irvine, CA 92603-4233 Ph: (949) 823-8915 |
News Archive
Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.
A naturally produced molecule called resveratrol, found in the skin of red grapes, has been shown to lower insulin levels in mice when injected directly into the brain, even when the animals ate a high-fat diet.
Arena Pharmaceuticals, Inc. announced today the initiation of patient screening in a Phase 1 clinical trial of APD916, a novel oral drug candidate discovered by Arena that targets the histamine H3 receptor for the treatment of narcolepsy and cataplexy.
ARIAD Pharmaceuticals, Inc. today announced the presentation of new preclinical data on its investigational pan-BCR-ABL inhibitor, ponatinib, and its investigational dual EGFR-ALK inhibitor, AP26113, at the American Association for Cancer Research Annual Meeting in Chicago.
› Verified 7 days ago
Anne Bowlus, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4139 Campus Dr, Irvine, CA 92612 Phone: 949-823-9762 | |
Jack Wu, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5695 Alton Pkwy, Irvine, CA 92618 Phone: 949-726-0716 | |
Dr. Tracy Lynn Robinson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13200 Jamboree Rd, T-1238, Irvine, CA 92602 Phone: 714-838-1209 | |
Neda Namdar, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14330 Culver Dr, Irvine, CA 92604 Phone: 949-559-8129 | |
Mr. John Michael Nguyen, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3875 Alton Pkwy, Irvine, CA 92606 Phone: 714-722-4720 | |
Mr. Seth Reilly Taylor, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13200 Jamboree Rd, Irvine, CA 92602 Phone: 714-838-7433 | |
Adam Azargoon, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9213 Research Dr, Irvine, CA 92618 Phone: 800-874-5881 |